AR
Highly rated in
6
conditions
Highly rated in
6
conditions
Check Dr. Adam Raben's experience treating your condition:
About Dr. Adam Raben

Adam Raben is a Radiation Oncologist in Newark, Delaware. Raben has been practicing medicine for over 32 years and is highly rated in 6 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma. He is licensed to treat patients in Maryland, Delaware, and New Jersey. Raben is currently accepting new patients.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Adam Raben it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Adam Raben accepts the following insurance:

  •  Ambetter
  •  Highmark

Call to see if your plan is accepted.
Locations
4701 Ogletown Stanton Rd, Newark, DE 19713
Other Locations
161 Wilmington W Chester Pike, Chadds Ford, PA 19317
4755 Ogletown Stanton Rd, Newark, DE 19718
Background & Education
Graduate Institution
Wake Forest University School Of Medicine, 1990
Specialties
Radiation Oncology
Licenses
Radiology in DE
Hospital Affiliations
Christiana Hospital
Wilmington Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
View 5 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors